Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma
NCT06985225 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2026-04-29
Summary
In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with severe asthma. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.
Conditions
Interventions
- COMBINATION_PRODUCT
-
Hyperpolarized 129 Xenon
Xenon gas contrast agent for MRI
Sponsors & Collaborators
-
Polarean Imaging, Plc
collaborator UNKNOWN -
University of Kansas Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
NCT04677426 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
NCT06012500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications
NCT04353661 ·Status: TERMINATED ·Phase: PHASE2
-
Structure and Function MRI of Asthma
NCT02351141 ·Status: RECRUITING ·Phase: NA
-
Functional Applications of Hyperpolarized 129Xe MRI
NCT01697332 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
NCT01710449 ·Status: COMPLETED ·Phase: PHASE1
-
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
NCT05816616 ·Status: WITHDRAWN
-
Regional Lung Imaging Using Hyperpolarized Xenon Gas
NCT02112929 ·Status: COMPLETED ·Phase: PHASE1
-
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis
NCT04071769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Functional MR Lung Imaging Using Hyperpolarised 129Xe
NCT02976935 ·Status: COMPLETED
-
Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection
NCT04584671 ·Status: ACTIVE_NOT_RECRUITING
-
Imaging Measures of Respiratory Health Registry
NCT05102825 ·Status: RECRUITING
-
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
NCT03002389 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
NCT06853145 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)
NCT07143747 ·Status: NOT_YET_RECRUITING
-
Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging
NCT02279329 ·Status: RECRUITING ·Phase: NA
-
Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
NCT02478268 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of 133Xe Scintigraphy With 19F MRI
NCT03532334 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease
NCT02723474 ·Status: COMPLETED ·Phase: NA
-
Oxidative Stress in Asthma
NCT04512547 ·Status: COMPLETED ·Phase: PHASE2
-
Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology
NCT06856525 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
NCT02748798 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Phenotyping Asthma for Bronchial Thermoplasty
NCT03435237 ·Status: RECRUITING
-
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
NCT04872309 ·Status: SUSPENDED
-
New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)
NCT02826343 ·Status: COMPLETED ·Phase: EARLY_PHASE1